Dr. Sturgis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1977 BUTLER BLVD
JAMAIL SPECIALTY CENTER - E5.200
Houston, TX 77030Phone+1 713-798-5900Fax+1 713-798-5078
Summary
- Dr. Sturgis is board certified and a professor with tenure in the Department of Otolaryngology-Head and Neck Surgery. He is Vice-chair of Clinical Affairs, holds the Brown Foundation Endowed Chair, and is the Head Neck and Thyroid Multidisciplinary Program Director. Prior to joining Baylor College of Medicine, he served for 23 years at MD Anderson Cancer Center caring for patients with complex head, neck, and thyroid cancers- with over 4,000 surgical patients. His surgical practice is focused on thyroid cancer, sarcomas of the head and neck region, and melanoma/non-melanoma skin cancers. He has devoted much of his academic career to HPV-related oropharyngeal cancer and working to broadly disseminate the message of preventive HPV vaccination. He has founded and led several multidisciplinary translational research and outreach efforts in HPV-related cancers. He is the national Head and Neck Surgical Chair for the national cooperative group trial network, NRG Oncology. Currently, he leads a clinical trial (Houston; NCT02897427, clinicaltrials.gov) of 1500 middle-aged men to develop a novel paradigm for screening for HPV-related cancers in men. He has more than 350 peer-reviewed publications, over 60 invited reviews/book chapters, and over 230 invited lectures; and has been recognized for his efforts in cancer prevention, mentoring, and education.
Education & Training
- The University of Texas Health Science Center School of Public HealthMaster in Public Health, 2002 - 2004
- University of Texas M D Anderson Cancer CenterFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 1999 - 2000
- University of Texas M D Anderson Cancer CenterFellowship, Molecular Epidemiology, 1997 - 1999
- Vrjie UniversityFellowship, Head and Neck Oncologic Surgery, 1996 - 1997
- Tulane UniversityResidency, Otolaryngology - Head and Neck Surgery, 1992 - 1996
- New York Presbyterian Hospital (Columbia and Cornell Campus)Fellowship, Otolaryngology - Head and Neck Surgery, 1991 - 1992
- Tulane UniversityInternship, Surgery, 1990 - 1991
- Georgetown University School of MedicineClass of 1990, Doctor of Medicine, MD, Cum Laude Graduate
- Louisiana State UniversityBachelor of Science, Biochemistry, Cum Laude, 1982 - 1985
Certifications & Licensure
- TX State Medical License 1998 - 2025
- LA State Medical License 1992 - 2011
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Faculty Achievement Award in Cancer Prevention The University of Texas MD Anderson Cancer Center, 2019
- President's Recognition of Faculty Award The University of Texas MD Anderson Cancer Center, 2019
Clinical Trials
- Throat and Other HPV-Related Cancers in Men: Identifying Them Early Start of enrollment: 2017 Mar 28
Publications & Presentations
PubMed
- 471 citationsDevelopment and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICO...Brian O'Sullivan, Shao Hui Huang, Jie Su, Adam S. Garden, Erich M. Sturgis
The Lancet. Oncology. 2016-04-01 - 342 citationsEpidemiology of HPV-associated oropharyngeal cancerKristen B. Pytynia, Kristina R. Dahlstrom, Erich M. Sturgis
Oral Oncology. 2014-05-01 - 130 citationsHuman Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists GuidelineCarole Fakhry, Christina Lacchetti, Lisa M. Rooper, Richard C.K. Jordan, Danny Rischin
Journal of Clinical Oncology. 2018-09-06
Journal Articles
- Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trialKristina R. Dahlstrom, Karen S. Anderson, Ming Guo, Michael C. Kwon, Craig A. Messick, Curtis A. Pettaway, Nancy Asomaning, Marika Hopper, Anthony Price, Li Xua, Andre..., Oral Oncology, 9/2021
- Risk and Clinical Risk Factors Associated with Late Lower Cranial Neuropathy in Long-Term Oropharyngeal Squamous Cell Carcinoma SurvivorsRyan P Goepfert, Stephen Y Lai, Renata Ferrarotto, Erich M Sturgis, JAMA Otolaryngology–Head & Neck Surgery
- Considerations in Human Papillomavirus–Associated Oropharyngeal Cancer ScreeningCarole Fakhry, Erich M Sturgis, JAMA Otolaryngology–Head & Neck Surgery
- Join now to see all
Authored Content
- Considerations in Human Papillomavirus–Associated Oropharyngeal Cancer ScreeningMay 2020
Press Mentions
- Preventing Throat Cancer: The Importance of Vaccination and ScreeningAugust 17th, 2021
- Baylor Recruiting Participants for Throat Cancer Screening StudyJune 14th, 2021
- Baylor College of Medicine Recruiting Participants for Throat Cancer Screening StudyJune 14th, 2021
- Join now to see all
Grant Support
- Establishment of a Prospective Cohort at Risk for HPV-Related Cancers: Using HPV Testing at Mucosal Sites and Blood-Based Assays for Risk Stratification in MenCancer Prevention & Research Institute of Texas2020–Present
- Use Of Serum HPV16 DNA As A Marker For Oropharyngeal Cancer RecurrenceNational Cancer Institute2007–2008
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: